Research Areas

Illustration of a cancer cell

Cancer

We push forward the leading edge of cancer genomics research by focusing on whole genome sequencing of individuals with cancer and their tumors, novel population-level cancer analytics, and the application of both single cell and spatial transcriptomics.

Computational Genomics

We develop and apply computational methods capable of extracting biological understanding from genomics data. These tools are publicly available and many are widely used by the broader scientific community.

COVID-19 Genomics

We apply our expertise in genomics and our role as a scientific convener in New York to accelerate and support COVID-19 genomics research. We believe the best chance of rapid progress will come through a network that pools together efforts and resources.

Genomic Technologies

We advance the development and deployment of novel genomic technologies, including molecular diagnostic testing, liquid biopsy, single-cell analysis, CRISPR gene editing, spatial transcriptomics, and other laboratory computational methods.
Neurodegenerative brain graphic

Neurodegenerative Disease

We leverage the success of our Center for Genomics of Neurodegenerative Disease's focus on ALS research to extend our work across a range of neurodegenerative diseases that share a common pathway with ALS, including dementia, ALS, Alzheimer's disease, frontotemporal dementia, Parkinson's disease, and Huntington's disease.
Illustration of a cross section of a human head in profile, showing the neuropsychiatric disease in the brain

Neuropsychiatric Disease

We broaden our robust research of the genetic architecture of autism using whole genome sequencing to the study of other neuropsychiatric disorders, including schizophrenia and bipolar disorder.